Home › Skin Conditions › Oregon › Portland
Skin Conditions clinical trials in Portland, OR
4 studies for Skin Conditions are looking for participants at sites in and around Portland (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
RecruitingPhase 3
- Northwest Dermatology Institute, Portland
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
RecruitingPhase 2
- Inmagene Site 3, Portland
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities
RecruitingPhase 3
- Oregon Dermatology and Research Center, Portland
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp
RecruitingPhase 3
- Oregon Dermatology and Research Center, Portland
About Skin Conditions
Your skin is your body's largest organ. It covers and protects your body. Learn about skin conditions, including causes, symptoms, and treatment.
More about Skin Conditions on MedlinePlus
Skin Conditions trials in other cities
- Indianapolis, IN4 studies
- Phoenix, AZ4 studies
- Hollywood, FL4 studies
- Los Angeles, CA4 studies
- Boston, MA3 studies
- Arlington Heights, IL3 studies
- Saint Joseph, MO3 studies
- Minneapolis, MN3 studies
- Santa Clarita, CA3 studies
- Tampa, FL3 studies
- New York City, NY3 studies
- Fargo, ND3 studies
Other studies in Portland
- Non-Small Cell Lung Cancer46 studies
- Cancer (all types)34 studies
- Breast Cancer33 studies
- Prostate Cancer33 studies
- Metastatic Cancer29 studies
- Colorectal Cancer28 studies
- Ovarian Cancer27 studies
- Lung Cancer26 studies
- Acute Myeloid Leukemia25 studies
- Endometrial Cancer24 studies
- Head and Neck Squamous Cell Carcinoma19 studies
- Pancreatic Cancer19 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.